Form D · Other
Waltz Health, Inc.
Chicago, IL · CIK 0001880783
Offering snapshot reported Nov 29, 2024 · SEC filing
- Reported sold
- $17.5M Offering amount: $20M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Nov 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2024 | Initial | $17,500,000 | No comparison | 4 | SEC filing |
| Jan 26, 2022 | Initial | $27,500,000 | No comparison | 3 | SEC filing |
| Aug 31, 2021 | Initial | $3,000,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530735
Source: Form D, filed Nov 29, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lynne Chou O'keefe | Director |
| Jeffrey Park | Director, Executive |
| Benjamin Robbins | Director |
| Mark Thierer | Director, Executive |
| Jonathon Thierer | Director |
Issuer details
Industry: Other (See others in industry)
Address:
351 W. Hubbard Street Suite 700
Chicago, IL, 60654
Chicago, IL, 60654